Andrew M. Goldsweig, MD, MS, FSCAI, RPVI is an assistant professor of interventional cardiology and associate cath lab director for structural heart disease at the University of Nebraska Medical Center (UNMC), where he initiated the LAA occlusion and PFO closure programs and performs TAVR and TMVr in addition to coronary and peripheral interventions.

His research interests include utilization and outcomes of structural heart disease procedures and radiation hazards in interventional cardiology. He also currently serves as a site investigator for several clinical trials including TAVR UNLOAD, Optimize PRO, CHAMPION-AF, ASAP TOO, TRANSCEND, MINT, and the National Cardiogenic Shock Initiative.

Andy is a member of the SCAI Structural Heart Disease Council, Publications Committee, and Government Relations Committee, as well as the social media editor for Catheterization and Cardiovascular interventions.  He also serves as Governor of the Nebraska Chapter of the ACC and is a member of the HeartPAC Advisory Board.